Facebook Live: ‘Immunocompromised Patients’ Response to COVID Vaccines – The OCTAVE study explained


Clare Jacklin, NRAS CEO in conversation with Professor Stefan Siebert of Glasgow University. The topic of discussion is to gain a better understanding of what the findings from the OCTAVE study tell us for those living with inflammatory arthritis.